T1	Participants 223 408	Seventy-eight children presenting with typical and extraesophageal symptoms of gastroesophageal reflux disease underwent a multichannel intraluminal impedance and pH monitoring (MII/pH)
T2	Participants 1170 1359	Only 5/16 (31.2 %) patients treated with H(2) RAs had a complete resolution of symptoms after 3 months; 1/11 was treated again with H(2) RAs during 3 months, and 10/11 were changed to PPIs.
T3	Participants 567 630	At the end of the treatment period, all patients were recalled.
T4	Participants 107 221	The effect of antisecretory treatment on extraesophageal symptoms of gastroesophageal reflux disease was evaluated
